The Net Margin of Ryvu Therapeutics SA (RVU.WA) is -142.92%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -142.92% |
| 2023-12-31 | -196.57% |
| 2022-12-31 | -215.12% |
| 2021-12-31 | -706.94% |
| 2020-12-31 | -202.47% |
| 2019-12-31 | 7520.15% |
| 2018-12-31 | -0.14% |
| 2017-12-31 | 9.49% |
| 2016-12-31 | 5.65% |
| 2015-12-31 | 15.28% |